Skip to main content

Table 1 Dose-volume objectives for target structures and organs at risk

From: Dosimetric evaluation of VMAT and helical tomotherapy techniques comparing conventional volumes with clinical target volumes based on new ESTRO ACROP post-mastectomy with immediate implant reconstruction contouring guidelines

Target structures

%95 of PTV and PTVp should receive > %95 of prescribed dose and D1 < 107% of prescribed dose

Heart

Dmax < 35 Gy

Dmean < 5 Gy

LAD

Dmax < 25 Gy

Dmean < 10 Gy

Ipsilateral lung

V20 < %20

V5 < %65

Contralateral lung

Dmax < 25 Gy

Dmean < 5 Gy

Contralateral breast

Dmax < 20 Gy

Dmean < 5 Gy

Implant

Dmean < 38 Gy

No hotspots inside

Implant-PTV

Dmean < 32 Gy

Liver

V20Gy < %1